These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31178408)

  • 1. A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling.
    Huang Y; Fang J; Lu W; Wang Z; Wang Q; Hou Y; Jiang X; Reizes O; Lathia J; Nussinov R; Eng C; Cheng F
    Cell Chem Biol; 2019 Aug; 26(8):1143-1158.e6. PubMed ID: 31178408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wogonoside inhibits angiogenesis in breast cancer via suppressing Wnt/β-catenin pathway.
    Huang Y; Zhao K; Hu Y; Zhou Y; Luo X; Li X; Wei L; Li Z; You Q; Guo Q; Lu N
    Mol Carcinog; 2016 Nov; 55(11):1598-1612. PubMed ID: 26387984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers.
    Di Mauro C; Rosa R; D'Amato V; Ciciola P; Servetto A; Marciano R; Orsini RC; Formisano L; De Falco S; Cicatiello V; Di Bonito M; Cantile M; Collina F; Chambery A; Veneziani BM; De Placido S; Bianco R
    Br J Cancer; 2017 May; 116(11):1425-1435. PubMed ID: 28441382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wogonoside impedes the progression of acute myeloid leukemia through inhibiting bone marrow angiogenesis.
    Lin B; Zhao K; Yang D; Bai D; Liao Y; Zhou Y; Yu Z; Yu X; Guo Q; Lu N
    J Cell Physiol; 2019 Feb; 234(2):1913-1924. PubMed ID: 30105796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An isoflavone derivative potently inhibits the angiogenesis and progression of triple-negative breast cancer by targeting the MTA2/SerRS/VEGFA pathway.
    Zhang X; Zou G; Li X; Wang L; Xie T; Zhao J; Wang L; Jiao S; Xiang R; Ye H; Shi Y
    Cancer Biol Med; 2020 Aug; 17(3):693-706. PubMed ID: 32944400
    [No Abstract]   [Full Text] [Related]  

  • 6. SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer.
    Li QW; Zhang GL; Hao CX; Ma YF; Sun X; Zhang Y; Cao KX; Li BX; Yang GW; Wang XM
    J Ethnopharmacol; 2021 Feb; 266():113430. PubMed ID: 33011366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells.
    Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T; Kurebayashi J
    Breast Cancer; 2017 Sep; 24(5):683-693. PubMed ID: 28144905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipalmitoylphosphatidic acid inhibits breast cancer growth by suppressing angiogenesis via inhibition of the CUX1/FGF1/HGF signalling pathway.
    Chen J; Zhou Z; Yao Y; Dai J; Zhou D; Wang L; Zhang QQ
    J Cell Mol Med; 2018 Oct; 22(10):4760-4770. PubMed ID: 30010249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wogonoside induces growth inhibition and cell cycle arrest via promoting the expression and binding activity of GATA-1 in chronic myelogenous leukemia cells.
    Li H; Hui H; Xu J; Yang H; Zhang X; Liu X; Zhou Y; Li Z; Guo Q; Lu N
    Arch Toxicol; 2016 Jun; 90(6):1507-22. PubMed ID: 26104856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wogonoside inhibits lipopolysaccharide-induced angiogenesis in vitro and in vivo via toll-like receptor 4 signal transduction.
    Chen Y; Lu N; Ling Y; Gao Y; Wang L; Sun Y; Qi Q; Feng F; Liu W; Liu W; You Q; Guo Q
    Toxicology; 2009 May; 259(1-2):10-7. PubMed ID: 19428938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indole-2-Carboxamide Derivative LG25 Inhibits Triple-Negative Breast Cancer Growth By Suppressing Akt/mTOR/NF-κB Signalling Pathway.
    Xu X; Rajamanickam V; Shu S; Liu Z; Yan T; He J; Liu Z; Guo G; Liang G; Wang Y
    Drug Des Devel Ther; 2019; 13():3539-3550. PubMed ID: 31631978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wogonoside induces apoptosis in human non-small cell lung cancer A549 cells by promoting mitochondria dysfunction.
    Luo M; Mo J; Yu Q; Zhou S; Ning R; Zhang Y; Su C; Wang H; Cui J
    Biomed Pharmacother; 2018 Oct; 106():593-598. PubMed ID: 29990847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scutellaria barbata D.Don and Scleromitrion diffusum (Willd.) R.J.Wang inhibits the progression of triple negative breast cancer though the activation inhibition of NF-κB triggered by CAFs-derived IL6.
    Pan Y; Ma T; Chen D; Wang Y; Peng Y; Lu T; Yin X; Li H; Zhang G; Wang X
    J Ethnopharmacol; 2024 Dec; 335():118656. PubMed ID: 39121924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of [1,2,4]triazolo[4,3-a]pyridines as potent Smoothened inhibitors targeting the Hedgehog pathway with improved antitumor activity in vivo.
    Tian N; Wu H; Zhang H; Yang D; Lv L; Yang Z; Zhang T; Quan D; Zhou L; Xie Y; Xu Y; Wei N; Zhang J; Chen M; Schmitz JC; Tian Y; Wu S
    Bioorg Med Chem; 2020 Aug; 28(16):115584. PubMed ID: 32690258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel VEGF receptor 2 inhibitor YLL545 inhibits angiogenesis and growth in breast cancer.
    Zhang J; Liu C; Shi W; Yang L; Zhang Q; Cui J; Fang Y; Li Y; Ren G; Yang S; Xiang R
    Oncotarget; 2016 Jul; 7(27):41067-41080. PubMed ID: 27203384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein.
    Song X; Yao J; Wang F; Zhou M; Zhou Y; Wang H; Wei L; Zhao L; Li Z; Lu N; Guo Q
    Toxicol Appl Pharmacol; 2013 Sep; 271(2):144-55. PubMed ID: 23707765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wogonoside inhibits tumor growth and metastasis in endometrial cancer via ER stress-Hippo signaling axis.
    Chen S; Wu Z; Ke Y; Shu P; Chen C; Lin R; Shi Q
    Acta Biochim Biophys Sin (Shanghai); 2019 Nov; 51(11):1096-1105. PubMed ID: 31696210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem-like tumor cells involved in heterogeneous vasculogenesis in breast cancer.
    Mao Y; Zhu L; Huang Z; Luo C; Zhou T; Li L; Wang G; Yang Z; Qi W; Yang X; Gao G
    Endocr Relat Cancer; 2020 Jan; 27(1):23-39. PubMed ID: 31705798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry.
    Sun H; Zhang D; Yao Z; Lin X; Liu J; Gu Q; Dong X; Liu F; Wang Y; Yao N; Cheng S; Li L; Sun S
    Cancer Biol Ther; 2017 Apr; 18(4):205-213. PubMed ID: 28278077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneously targeting cancer-associated fibroblasts and angiogenic vessel as a treatment for TNBC.
    Sharma M; Turaga RC; Yuan Y; Satyanarayana G; Mishra F; Bian Z; Liu W; Sun L; Yang J; Liu ZR
    J Exp Med; 2021 Apr; 218(4):. PubMed ID: 33561195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.